Stonepine Capital Management, LLC Rigel Pharmaceuticals Inc Transaction History

Stonepine Capital Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$1.12 - $1.57 $1.17 Million - $1.63 Million	1,040,241 New	1,040,241 $1.54 Billion
Q2 2020 Aug 13, 2020	SELL	$1.41 - $2.05 $14,100 - $20,500	-10,000 Closed	0 $0
Q1 2020 May 14, 2020	BUY	$1.27 - $3.0 $12,700 - $30,000	10,000 New	10,000 $16,000
Q3 2018 Nov 13, 2018	SELL	$2.6 - $3.59 $3.89 Million - $5.37 Million	-1,496,590 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$2.83 - $4.11 $4.24 Million - $6.15 Million	1,496,590 New	1,496,590 $4.24 Million

334K

Ticker RIGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 172,836,000
Market Cap $2.96B
Description
Rigel Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs to treat hematologic disorders, cancer, and rare immune diseases. The company offers Tavalisse, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia. It also develops Fostamatinib that is ...

Get notified when there are updates to the investment portfolio of Stonepine Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Stonepine Capital Management, LLC with notifications on news.